Anne Hoskins
Psychiatric/Mental Health · New Albany, INNPI 1205999240
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.9% of the total across 898 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 32 manufacturers, the largest accounting for just 17.5% — the pattern of someone who eats at a lot of different presentations. Among psychiatric/mental health clinicians in IN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 898 payments — averaging $12.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Supernus Pharmaceuticals, Inc.$1K
- Takeda Pharmaceuticals U.S.A., Inc.$974
- Otsuka America Pharmaceutical, Inc.$911
- Corium, LLC$869
- Neos Therapeutics, LP$646
- plus $5K from 26 others
What the payments were for
- Food & beverage$11,529100%
- Education$80%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 187 | $2,017 |
| Supernus Pharmaceuticals, Inc. | 105 | $1,072 |
| Takeda Pharmaceuticals U.S.A., Inc. | 75 | $974 |
| Otsuka America Pharmaceutical, Inc. | 79 | $911 |
| Corium, LLC | 67 | $869 |
| Neos Therapeutics, LP | 72 | $646 |
| Lundbeck LLC | 38 | $591 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 36 | $572 |
| Noven Therapeutics, LLC | 37 | $562 |
| Axsome Therapeutics, Inc. | 31 | $485 |
| Alkermes, Inc. | 32 | $484 |
| Johnson & Johnson | 28 | $475 |
| Ironshore Pharmaceuticals Inc. | 27 | $377 |
| Vanda Pharmaceuticals Inc. | 16 | $336 |
| Tris Pharma Inc | 12 | $196 |
| Idorsia Pharmaceuticals US Inc | 8 | $137 |
| Avanir Pharmaceuticals, Inc. | 6 | $105 |
| Adlon Therapeutics L.p. | 7 | $100 |
| Teva Pharmaceuticals USA, Inc. | 5 | $90 |
| Bausch Health US, LLC | 4 | $82 |
| Sunovion Pharmaceuticals Inc. | 4 | $79 |
| Collegium Pharmaceutical, Inc. | 4 | $78 |
| Almatica Pharma LLC | 5 | $73 |
| Merck | 3 | $66 |
| Vertical Pharmaceuticals, LLC | 3 | $40 |
| OWP Pharmaceuticals, Inc. | 1 | $21 |
| USWM, LLC | 1 | $21 |
| Neurocrine Biosciences, Inc. | 1 | $18 |
| Jazz Pharmaceuticals Inc. | 1 | $17 |
| E.r. Squibb & Sons, L.L.C. | 1 | $16 |
| Neuronetics, Inc. | 1 | $16 |
| Alfasigma USA, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- QELBREE$130
How this compares
$11,537 in reported general payments places this provider in the 95th percentile of 729 psychiatric/mental health providers in Indiana.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 25 | $568 |
| Desvenlafaxine Succinate ErDesvenlafaxine Succinate | 11 | $428 |
| Hydroxyzine Pamoate | 17 | $295 |
| Lamotrigine | 17 | $161 |
| Sertraline Hcl | 14 | $133 |
| Buspirone Hcl | 13 | $119 |
| Clonazepam | 26 | $104 |
| Escitalopram Oxalate | 12 | $94 |
| Lorazepam | 11 | $87 |
| Alprazolam | 25 | $30 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Almatica Pharma LLCSertraline Hcl | $73 | $13314 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 729 psychiatric/mental health providers in Indiana.
Other psychiatric/mental health in New Albany
- Brooke KempfTerre Haute$1.1M
- Gerald LewisMerrillville$336K
- Lauren LutzColumbus$320K
- Sonya RuedlingerIndianapolis$134K
- Trina GreenwaldMarion$107K
- Paul DuncanJeffersonville$46K
- Morgan StamperConnersville$42K
- Jennifer JimenezUnion Mills$37K
- Savannah MullinsClarksville$31K
- Sharon ClevengerFort Wayne$22K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.